Cortrosyn
Generic: COSYNTROPIN
Basic Information
Manufacturer
Amphastar Pharmaceuticals, Inc.
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
INTRAMUSCULAR
FDA Set ID
746856e9-3930-4f6a-b8e6-a03845d6dd0b
Indications & Usage
1 INDICATIONS AND USAGE CORTROSYN is indicated, in combination with other diagnostic tests, for use as a diagnostic agent in the screening of adrenocortical insufficiency in adults and pediatric patients.
CORTROSYN is an adrenocorticotropin hormone indicated, in combination with other diagnostic tests, for use as a diagnostic agent in the screening of adrenocortical insufficiency in adults and pediatric patients.
CORTROSYN is an adrenocorticotropin hormone indicated, in combination with other diagnostic tests, for use as a diagnostic agent in the screening of adrenocortical insufficiency in adults and pediatric patients.
Adverse Reactions
6 ADVERSE REACTIONS Because adverse reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
The following adverse reactions have been identified during post approval use of CORTROSYN: anaphylactic reaction bradycardia tachycardia hypertension peripheral edema rash Most common adverse reactions are: anaphylactic reaction, bradycardia, tachycardia, hypertension, peripheral edema, and rash To report SUSPECTED ADVERSE REACTIONS, contact Amphastar Pharmaceuticals, Inc.
at 1-800-423-4136 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
The following adverse reactions have been identified during post approval use of CORTROSYN: anaphylactic reaction bradycardia tachycardia hypertension peripheral edema rash Most common adverse reactions are: anaphylactic reaction, bradycardia, tachycardia, hypertension, peripheral edema, and rash To report SUSPECTED ADVERSE REACTIONS, contact Amphastar Pharmaceuticals, Inc.
at 1-800-423-4136 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.